Article
Cardiac & Cardiovascular Systems
Sean Agbor-Enoh, Palak Shah, Ilker Tunc, Steven Hsu, Stuart Russell, Erika Feller, Keyur Shah, Maria E. Rodrigo, Samer S. Najjar, Hyesik Kong, Mehdi Pirooznia, Ulgen Fideli, Alfiya Bikineyeva, Argit Marishta, Kenneth Bhatti, Yanqin Yang, Cedric Mutebi, Kai Yu, Moon Kyoo Jang, Charles Marboe, Gerald J. Berry, Hannah A. Valantine
Summary: This study validated the use of %ddcfDNA as a sensitive blood biomarker for detecting acute rejection in cardiac transplant recipients. It showed excellent performance characteristics in early detection and could potentially reduce the need for invasive endomyocardial biopsies.
Article
Medicine, General & Internal
Noelia Garcia-Fernandez, Hada C. Macher, Gonzalo Suarez-Artacho, Miguel Angel Gomez-Bravo, Patrocinio Molinero, Juan Miguel Guerrero, Manuel Porras-Lopez, Amalia Rubio
Summary: This study used a qPCR method to detect donor-specific cfDNA in the serum of liver transplant recipients. The results showed that ds-cfDNA levels can differentiate between rejection and liver damage. By setting a threshold, ds-cfDNA could be a useful marker for screening rejection and liver damage.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Immunology
Yunhui Li, Bin Liang
Summary: This study analyzed the levels of circulating dd-cfDNA in different types of graft rejection and evaluated its diagnostic potential in predicting graft rejection after lung transplantation. The results showed that circulating dd-cfDNA levels were significantly higher in graft rejection, ACR, and AMR compared to non-rejection. Circulating dd-cfDNA could be used as a non-invasive biomarker to distinguish patients with graft rejection from normal stable controls.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Oncology
Jeroen G. H. P. Verhoeven, Carla C. Baan, Annemiek M. A. Peeters, Marian C. Clahsen-van Groningen, Daan Nieboer, Marielle Herzog, Marc Eccleston, Dennis A. Hesselink, Karin Boer
Summary: In this pilot study, total circulating cell-free nucleosomes (H3) concentrations are increased during acute kidney transplant rejection. The high negative predictive value suggests that when a patient experiences loss of renal transplant function and total CCFN (H3) is not increased, causes other than acute rejection should be considered. Clinical implementation of total CCFN (H3) measurement may help avoid unnecessary and potentially harmful kidney transplant biopsies.
CLINICAL EPIGENETICS
(2021)
Article
Cardiac & Cardiovascular Systems
Amar Doshi, Keyur B. Shah, Sean Agbor-Enoh, Zackary Tushak, Victoria Garcia, Hyesik Kong, Moon K. Jang, Steven Hsu, Erika D. Feller, Maria E. Rodrigo, Samer S. Najjar, Ilker Tunc, Yanqin Yang, Seiyon Lee, Michael A. Solomon, Gerald Berry, Charles Marboe, Palak Shah, Hannah A. Valantine
Summary: Black patients who undergo heart transplantation have higher rates of antibody-mediated rejection and worse long-term graft survival. Donor-derived cell free DNA (ddcfDNA) is released into the blood after allograft injury. This study found that immediately after transplant, Black patients had higher levels of %ddcfDNA. In the first week post-transplant, the rate of decay in %ddcfDNA was similar for both Black and non-Black patients. Black patients were also more likely to receive a race mismatched organ, which may explain the higher levels of early allograft injury.
JOURNAL OF HEART AND LUNG TRANSPLANTATION
(2022)
Review
Immunology
Annette M. Jackson, Carly Amato-Menker, Maria Bettinotti
Summary: Using NGS to interrogate cfDNA improves accuracy in post-transplant monitoring, revealing mechanisms of injury. Monitoring donor-derived cfDNA aids in identifying allograft injury and rejection, providing minimally invasive, quantitative measures across organ types.
Review
Immunology
Edward John Filippone, John L. Farber
Summary: Cell-free DNA (cfDNA) in solid organ transplantation can be used as a noninvasive method to identify acute rejection, with the potential for early detection of subclinical rejection in stable patients. However, levels of donor-derived cfDNA (ddcfDNA) are influenced by various factors and cannot completely replace traditional biopsy for diagnosis. Further randomized controlled trials are needed to validate the efficacy and cost-effectiveness of using cfDNA for monitoring rejection in organ transplant patients.
Review
Immunology
Saeedeh Salehi, Shima Afzali, Abbas Shahi, Ali Akbar Amirzargar, Yaser Mansoori
Summary: Organ transplantation is the preferred treatment for end-stage organ diseases, but allograft rejection remains a major obstacle to long-term survival. Long noncoding RNAs (lncRNAs) have been proposed as potential targets for prediction, prognosis, diagnosis, and treatment of graft rejection. Noninvasive predictive biomarkers hold promise to overcome the limitations of traditional tissue biopsy. This review provides a comprehensive overview of lncRNAs and their role in facilitating the diagnosis, prognosis, and prediction of graft rejection, and suggests therapeutic choices after transplantation.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Medicine, General & Internal
Adrian Martuszewski, Patrycja Paluszkiewicz, Magdalena Krol, Miroslaw Banasik, Marta Kepinska
Summary: This paper summarises the promising results related to cfDNA in transplant patients, highlighting the potential of donor-derived cell-free DNA in early diagnosis of transplant injury to prevent premature graft loss.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Medicine, General & Internal
Bilgin Osmanodja, Aylin Akifova, Michael Oellerich, Julia Beck, Kirsten Bornemann-Kolatzki, Ekkehard Schuetz, Klemens Budde
Summary: Donor-derived cell-free DNA (dd-cfDNA) is used as a biomarker for detection of graft injury and guidance of immunosuppressive therapy. A study on 22 kidney transplant recipients found that the conversion to belatacept led to an increase in absolute dd-cfDNA levels. Rating: 7 out of 10.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Surgery
Sam Kant, Daniel C. Brennan
Summary: The routine surveillance of kidney transplant allografts relies on imperfect biomarkers, but donor derived cell free DNA has shown potential as a better alternative for detection of allograft rejection, as well as other indications.
TRANSPLANT INTERNATIONAL
(2022)
Article
Surgery
Katharina A. Mayer, Konstantin Doberer, Amanda Tillgren, Thierry Viard, Susanne Haindl, Sebastian Krivanec, Roman Reindl-Schwaighofer, Michael Eder, Farsad Eskandary, Silvia Casas, Markus Wahrmann, Heinz Regele, Georg A. Boehmig
Summary: Circulating donor-specific antibodies do not always lead to antibody-mediated rejection. Monitoring donor-derived cell-free DNA levels can help improve diagnostic accuracy for ABMR in kidney transplant recipients with DSA.
TRANSPLANT INTERNATIONAL
(2021)
Article
Immunology
Pascal Pedini, Benjamin Coiffard, Nicem Cherouat, Sylvia Casas, Frederic Fina, Audrey Boutonnet, Jean Baptiste Baudey, Printil Aho, Agnes Basire, Sophie Simon, Coralie Frassati, Jacques Chiaroni, Martine Reynaud-Gaubert, Christophe Picard
Summary: This study aims to determine the clinical relevance of donor-derived cfDNA and cfDNA fragment size profiles in events such as acute rejection or infection during the first month after lung transplantation. The results show that the percentage of donor-derived cfDNA is higher in injured graft patients, and quantification of small sizes of DNA can accurately identify infection. Therefore, combining the quantification of donor-derived cfDNA and small DNA sizes can classify different types of graft injuries.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Surgery
Evangelos Mantios, Vassilis Filiopoulos, Pantelis Constantoulakis, George Liapis, Angeliki Vittoraki, Silvia Casas, Smaragdi Marinaki, John N. Boletis
Summary: In this study, blood samples from newly kidney transplanted patients and patients who underwent biopsy were analyzed to evaluate the effectiveness of dd-cfDNA in diagnosing rejection, monitoring treatment, and predicting long-term outcomes. The results showed that dd-cfDNA outperformed creatinine in diagnosing rejection and high levels of dd-cfDNA were associated with non-increasing eGFR one year after transplantation.
TRANSPLANT INTERNATIONAL
(2023)
Article
Gastroenterology & Hepatology
Hiroki Kanamori, Yohei Yamada, Yoko Ito, Koji Shirosaki, Satoko Yamagishi, Yutaro Maeda, Yumi Kudo, Tomoshige Umeyama, Nobuhiro Takahashi, Mototoshi Kato, Yasushi Hasegawa, Kentaro Matsubara, Masahiro Shinoda, Hideaki Obara, Rie Irie, Hanako Tsujikawa, Hajime Okita, Phuong Thanh Nguyen, Kenichi Saigo, Shigeki Mitsunaga, Ituro Inoue, Yuko Kitagawa, Tatsuo Kuroda
Summary: Donor-derived cell-free DNA (dd-cfDNA) serves as a sensitive biomarker for detecting graft injuries in Japanese liver transplantation (LTx). The levels of dd-cfDNA are significantly higher in samples obtained during acute rejection (AR) and have a stronger correlation with the rejection activity index (RAI).
HEPATOLOGY RESEARCH
(2023)
Article
Medical Laboratory Technology
Jose D. Santotoribio, Jose L. Cabrera-Alarcon, Paula Batalha-Caetano, Hada C. Macher, Juan M. Guerrero
CLINICAL BIOCHEMISTRY
(2015)
Letter
Peripheral Vascular Disease
Pablo Stiefel, Maria L. Miranda, Hada Macher, Luis M. Beltran-Romero, Rocio Munoz-Hernandez
HYPERTENSION RESEARCH
(2017)
Article
Agriculture, Multidisciplinary
Blanca Escudero-Lopez, Angeles Ortega, Isabel Cerrillo, Maria-Rosario Rodriguez-Grinolo, Rocio Munoz-Hernandez, Hada C. Macher, Franz Martin, Damaso Hornero-Mendez, Pedro Mena, Daniele Del Rio, Maria-Soledad Fernandez-Pachon
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
(2018)
Article
Multidisciplinary Sciences
Rocio Munoz-Hernandez, Antonio J. Vallejo-Vaz, Angeles Sanchez Armengol, Rafael Moreno-Luna, Candela Caballero-Eraso, Hada C. Macher, Jose Villar, Ana M. Merino, Javier Castell, Francisco Capote, Pablo Stiefel
Article
Hematology
Marta Ferro, Hada C. Macher, Gema Fornes, Jesus Martin-Sanchez, Pilar Jimenez-Arriscado, Patrocinio Molinero, Jose A. Perez-Simon, Juan M. Guerrero, Amalia Rubio
Article
Medicine, General & Internal
Myriam Ley-Martos, Juan M. Guerrero, Marta Lucas-Javato, Cristina Remon-Garcia, J. Raul Garcia-Lozano, Cristobal Colon, Pablo Crujeiras, Daniel Rodrigues, Pedro Paul-Sanchez, Hada C. Macher
Editorial Material
Medicine, General & Internal
Josep Oriola, Pilar Carrasco, Orland Diez, Begona Ezquieta
Article
Medical Laboratory Technology
Esperanza Lepe-Balsalobre, Jose D. Santotoribio, Ramiro Nunez-Vazquez, Salvador Garcia-Morillo, Pilar Jimenez-Arriscado, Paula Hernandez-Arevalo, Rocio Delarosa-Rodriguez, Juan M. Guerrero, Hada C. Macher
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
(2020)
Article
Genetics & Heredity
Rocio Delarosa-Rodriguez, Jose D. Santotoribio, Hernandez-Arevalo Paula, Antonio Gonzalez-Meneses, Salvador Garcia-Morillo, Pilar Jimenez-Arriscado, Juan M. Guerrero, Hada C. Macher
Summary: This study demonstrated the feasibility of using dried blood spot samples for the definitive diagnosis of Fabry disease in both males and females, with alpha-galactosidase A activity measurement being more sensitive than lyso-Gb3 levels. The study also identified novel pathogenic variants of the GLA gene in confirmed FD patients.
Article
Genetics & Heredity
Paula Hernandez-Arevalo, Jose D. Santotoribio, Rocio Delarosa-Rodriguez, Antonio Gonzalez-Meneses, Salvador Garcia-Morillo, Pilar Jimenez-Arriscado, Juan M. Guerrero, Hada C. Macher
Summary: This study identified genetic variations and clinical features in Spanish subjects with Pompe disease, establishing genotype-phenotype correlation. Four new genetic variants were reported, contributing to the spectrum of pathogenic variants of the GAA gene. Patients in Spain exhibit a characteristic profile of a European population, with specific prevalent variants and one variant associated with early disease and worse prognosis.
ORPHANET JOURNAL OF RARE DISEASES
(2021)
Article
Oncology
Javier Padillo-Ruiz, Gonzalo Suarez, Sheila Pereira, Francisco Jose Calero-Castro, Jose Tinoco, Luis Marin, Carmen Bernal, Carmen Cepeda-Franco, Jose Maria Alamo, Francisco Almoguera, Hada C. Macher, Paula Villanueva, Francisco Jose Garcia-Fernandez, Inmaculada Gallego, Manuel Romero, Miguel Angel Gomez-Bravo, Valeria Denninghoff, Maria Jose Serrano
Summary: This study found that the number of circulating tumor cells in portal blood can predict the risk of death in patients with early pancreatic cancer, and the number of clustered circulating tumor cells can reflect the degree of tumor differentiation.
Letter
Pediatrics
Jose D. Santotoribio, Esperanza Lepe Balsalobre, Irene Alonso Perez, Andrea Campo Barasoain, Hada C. Macher
ANALES DE PEDIATRIA
(2021)
Article
Peripheral Vascular Disease
Rocio Munoz-Hernandez, Pablo Medrano-Campillo, Maria L. Miranda, Hada C. Macher, Jose Manuel Praena-Fernandez, Antonio J. Vallejo-Vaz, Maria J. Dominguez-Simeon, Rafael Moreno-Luna, Pablo Stiefel
AMERICAN JOURNAL OF HYPERTENSION
(2017)
Article
Medical Laboratory Technology
Jiansheng Lin, Weihua Lin, Yiming Lin, Weilin Peng, Zhenzhu Zheng
Summary: This study retrospectively analyzed the cases of Chinese infants with NICCD and identified multiple genetic mutations. The study also found comorbidity of NICCD and other inborn errors of metabolism in some patients.
CLINICA CHIMICA ACTA
(2024)
Review
Medical Laboratory Technology
Lihua Guan, Wei Su, Jian Zhong, Ling Qiu
Summary: Multiple myeloma is characterized by excessive production of monoclonal immunoglobulins. Routine screening methods are insufficient for detecting low levels of M proteins, but advances in mass spectrometry enable reliable detection of low abundance serum biomarkers for minimal residual disease assessment in multiple myeloma.
CLINICA CHIMICA ACTA
(2024)
Article
Medical Laboratory Technology
Liya Zhu, Chao Zhu, Jialie Jin, Jinxin Wang, Xiaojing Zhao, Rongxi Yang
Summary: This study found an association between blood-based ITGB2 methylation and coronary heart disease (CHD), with hypomethylation of ITGB2 being a risk factor for CHD. Additionally, the combination of ITGB2 methylation and conventional CHD risk factors could efficiently discriminate CHD patients from controls.
CLINICA CHIMICA ACTA
(2024)
Article
Medical Laboratory Technology
H. Al Habobe, E. B. Haverkort, K. Nazmi, A. P. Van Splunter, R. H. H. Pieters, F. J. Bikker
Summary: Saliva diagnostics have become popular due to their non-invasive nature and patient-friendly collection process. However, the choice of saliva collection method can affect the measured levels of various biomarkers.
CLINICA CHIMICA ACTA
(2024)
Article
Medical Laboratory Technology
Abdurrahman Coskun, Anna Carobene, Ozlem Demirelce, Michele Mussap, Federica Braga, Ebru Sezer, Aasne Karine Aarsand, Sverre Sandberg, Pilar Fernandez Calle, Jorge Diaz-Garzon, Metincan Erkaya, Cihan Coskun, Esila Nur Erol, Hunkar Dag, Bill Bartlett, Mustafa Serteser, Niels Jonker, Ibrahim Unsal
Summary: In this study, BV estimates for 22 AAs were provided based on a large sample size, and it was found that there are differences in CVI estimates between males and females for most AAs, which has implications for the clinical interpretation and use of AAs.
CLINICA CHIMICA ACTA
(2024)
Review
Medical Laboratory Technology
Valentinus Besin, Farizky Martriano Humardani, Trilis Yulianti, Matthew Justyn
Summary: The study of Parkinson's Disease in Asian populations has revealed the impact of genetic variants on multiple biological pathways and highlighted shared genetic susceptibility with other diseases. These findings emphasize the importance of personalized treatment based on individual genetic profiles.
CLINICA CHIMICA ACTA
(2024)
Review
Medical Laboratory Technology
Simona Ferraro, Sara Benedetti, Savina Mannarino, Santica Marcovina, Elia Mario Biganzoli, Gianvincenzo Zuccotti
Summary: Risk stratification for cardio-vascular disease should be implemented in childhood to promote early prevention strategies, as atherosclerotic lesions can be present even in very young individuals. Evaluating pediatric CV risk factors/clinical conditions and conducting lipid profile and genetic testing can help identify children at risk of future CV events and guide appropriate therapeutic options.
CLINICA CHIMICA ACTA
(2024)
Review
Medical Laboratory Technology
Ahmad Mobed, Bita Abdi, Sajjad Masoumi, Mohammad Mikaeili, Elham Shaterian, Hamed Shaterian, Esmat Sadat Kazemi, Mahdiye Shirafkan
Summary: Reproductive biomarkers play important regulatory roles in women. The discovery and quantification of these biomarkers are clinically significant. Various detection strategies, including nanotechnology-based methods, have been developed. This article provides an in-depth introduction to the latest advances in biosensor and nanosensor research for detecting and quantitatively identifying reproductive biomarkers.
CLINICA CHIMICA ACTA
(2024)
Article
Medical Laboratory Technology
Chengfang Tang, Fang Tang, Yanna Cai, Minyi Tan, Sichi Liu, Ting Xie, Xiang Jiang, Yonglan Huang
Summary: This study proposes an effective method for screening X-ALD and evaluates the performance of newborn screening for X-ALD in Guangzhou. The LC-MS/MS method can accurately identify X-ALD through analysis of C26:0-LPC.
CLINICA CHIMICA ACTA
(2024)
Article
Medical Laboratory Technology
Lan Liu, Jiamin Wang, Xijing Liu, Jing Wang, Lin Chen, Hongmei Zhu, Jingqun Mai, Ting Hu, Shanling Liu
Summary: The 16p11.2 deletion is a common genetic cause of neurodevelopmental disorders, with prenatal and postnatal presentations including vertebral malformations and language impairment. The majority of deletions are de novo and may be associated with MAPK3 and histidine-associated metabolism.
CLINICA CHIMICA ACTA
(2024)
Article
Medical Laboratory Technology
Sneha Venkatesalu, Shanmugapriya Dilliyappan, Avanthika Satish Kumar, Thirunavukkarasu Palaniyandi, Gomathy Baskar, Maddaly Ravi, Asha Sivaji
Summary: Microfluidics is a science and technology that deals with less sample-to-more precision in vitro analysis. It has wide applications in cancer theranostics, enabling precise diagnosis and personalized treatment.
CLINICA CHIMICA ACTA
(2024)
Review
Medical Laboratory Technology
Yuanqin Zhao, Wei Deng, Zhaoyue Wang, Yanxia Wang, Hongyu Zheng, Kun Zhou, Qian Xu, Le Bai, Huiting Liu, Zhong Ren, Zhisheng Jiang
Summary: The cardiovascular system and the central nervous system exhibit a coordinated developmental process during embryonic development. Congenital heart disease (CHD) is the most common congenital disorder, and neurodevelopmental disorders (NDD) are common complications in CHD patients. Both genetic and non-genetic factors contribute to the co-occurrence of CHD and NDD. Further research should focus on identifying common molecular mechanisms underlying this co-occurrence and promoting the research and treatment of developmental disorders related to the cardiovascular and central nervous systems.
CLINICA CHIMICA ACTA
(2024)
Article
Medical Laboratory Technology
Karol Gostomczyk, Ewelina Lukaszewska, Jedrzej Borowczak, Anita Bator, Marek Zdrenka, Magdalena Bodnar, Lukasz Szylberg
Summary: Flow cytometry improves the detection of epithelial cancer cells in peritoneal and pleural fluids compared to conventional cytology. Due to similar speciflcity and higher sensitivity, flow cytometry offers a promising alternative to cytology for patient screening.
CLINICA CHIMICA ACTA
(2024)
Article
Medical Laboratory Technology
Heping Tian, Genghuan Wang, Qi Zhong, Haihang Zhou
Summary: This study found that the decline of serum ITIH4 concentrations during the early phase after aneurysmal subarachnoid hemorrhage (aSAH) was closely related to the severity and poor prognosis of the disease. Serum ITIH4 may represent a promising prognostic biomarker of aSAH.
CLINICA CHIMICA ACTA
(2024)
Article
Medical Laboratory Technology
Xueting Zhu, Yang Yu, Jun Zhang, Yuxia Zhan, Guanghua Luo, Lu Zheng
Summary: This study successfully established a 2D-PCR method for identifying HLA-B*15:02 through a two-tube reaction. This method can distinguish HLA-B*15:02 from 16 highly homologous HLA-B*15 alleles. Among 1830 samples from the clinical general population, 3 HLA-B*15:02 homozygotes and 84 HLA-B*15:02 heterozygotes were detected.
CLINICA CHIMICA ACTA
(2024)